Class information for:
Level 1: BASAL CELL CARCINOMA CELLS//NIJMEGEN MOL LIFE SCI 278//SILTUXIMAB

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
20921 441 47.3 92%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
422 3       C REACTIVE PROTEIN//STAT3//HAPTOGLOBIN 28303
1852 2             INTERLEUKIN 1//INTERLEUKIN 1 RECEPTOR ANTAGONIST//POLYMORPHISM 6090
20921 1                   BASAL CELL CARCINOMA CELLS//NIJMEGEN MOL LIFE SCI 278//SILTUXIMAB 441

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 BASAL CELL CARCINOMA CELLS authKW 138480 0% 100% 2
2 NIJMEGEN MOL LIFE SCI 278 address 138480 0% 100% 2
3 SILTUXIMAB authKW 99697 1% 24% 6
4 HUMAN OVARIAN TISSUES authKW 92319 0% 67% 2
5 UNIT HUMAN TUMOR IMMUNOBIOL address 92319 0% 67% 2
6 ALPHA PAK authKW 69240 0% 100% 1
7 APOPTOSIS INDUCTORS authKW 69240 0% 100% 1
8 AS IL6 authKW 69240 0% 100% 1
9 ASCITES AND METASTASIS authKW 69240 0% 100% 1
10 ASCITIC FLUID T LYMPHOCYTE authKW 69240 0% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Oncology 4680 53% 0% 234
2 Cell Biology 510 19% 0% 83
3 Urology & Nephrology 292 8% 0% 36
4 Immunology 189 12% 0% 51
5 Biochemistry & Molecular Biology 110 17% 0% 76
6 Endocrinology & Metabolism 85 7% 0% 29
7 Medicine, Research & Experimental 78 6% 0% 27
8 Obstetrics & Gynecology 59 4% 0% 19
9 Pathology 34 3% 0% 14
10 Genetics & Heredity 11 4% 0% 16

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 NIJMEGEN MOL LIFE SCI 278 138480 0% 100% 2
2 UNIT HUMAN TUMOR IMMUNOBIOL 92319 0% 67% 2
3 BIDMC GENOMICS 69240 0% 100% 1
4 BIOCHEM MOL BIOL ANAT 69240 0% 100% 1
5 CANC BIOSTAT BIOSTAT 69240 0% 100% 1
6 CANC DEV NIH 69240 0% 100% 1
7 CANC INFLAMMAT CANC 69240 0% 100% 1
8 CATTEDRA ONCOL MED INTERNAL MED ALLERGY CLIN 69240 0% 100% 1
9 CESI GD ANNUNZIO 69240 0% 100% 1
10 CHRISTIE HOSP MED ONCOL 69240 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 PROSTATE 6078 5% 0% 20
2 CYTOKINE 3509 3% 0% 15
3 EUROPEAN CYTOKINE NETWORK 3438 2% 1% 7
4 CLINICAL CANCER RESEARCH 1029 3% 0% 15
5 CANCER RESEARCH 992 5% 0% 24
6 ANTICANCER RESEARCH 795 3% 0% 15
7 CYTOKINE & GROWTH FACTOR REVIEWS 773 1% 0% 3
8 IDRUGS 739 0% 1% 2
9 NEOPLASIA 651 1% 0% 4
10 CANCER LETTERS 557 2% 0% 10

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 BASAL CELL CARCINOMA CELLS 138480 0% 100% 2 Search BASAL+CELL+CARCINOMA+CELLS Search BASAL+CELL+CARCINOMA+CELLS
2 SILTUXIMAB 99697 1% 24% 6 Search SILTUXIMAB Search SILTUXIMAB
3 HUMAN OVARIAN TISSUES 92319 0% 67% 2 Search HUMAN+OVARIAN+TISSUES Search HUMAN+OVARIAN+TISSUES
4 ALPHA PAK 69240 0% 100% 1 Search ALPHA+PAK Search ALPHA+PAK
5 APOPTOSIS INDUCTORS 69240 0% 100% 1 Search APOPTOSIS+INDUCTORS Search APOPTOSIS+INDUCTORS
6 AS IL6 69240 0% 100% 1 Search AS+IL6 Search AS+IL6
7 ASCITES AND METASTASIS 69240 0% 100% 1 Search ASCITES+AND+METASTASIS Search ASCITES+AND+METASTASIS
8 ASCITIC FLUID T LYMPHOCYTE 69240 0% 100% 1 Search ASCITIC+FLUID+T+LYMPHOCYTE Search ASCITIC+FLUID+T+LYMPHOCYTE
9 ASYMPTOMATIC INFLAMMATORY PROSTATITIS NIH CATEGORY IV 69240 0% 100% 1 Search ASYMPTOMATIC+INFLAMMATORY+PROSTATITIS+NIH+CATEGORY+IV Search ASYMPTOMATIC+INFLAMMATORY+PROSTATITIS+NIH+CATEGORY+IV
10 BASAL CELL CARCINOMA CELL LINE 69240 0% 100% 1 Search BASAL+CELL+CARCINOMA+CELL+LINE Search BASAL+CELL+CARCINOMA+CELL+LINE

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 NGUYEN, DP , LI, JY , TEWARI, AK , (2014) INFLAMMATION AND PROSTATE CANCER: THE ROLE OF INTERLEUKIN 6 (IL-6).BJU INTERNATIONAL. VOL. 113. ISSUE 6. P. 986-992 26 48% 28
2 GUO, YQ , XU, F , LU, TJ , DUAN, ZF , ZHANG, Z , (2012) INTERLEUKIN-6 SIGNALING PATHWAY IN TARGETED THERAPY FOR CANCER.CANCER TREATMENT REVIEWS. VOL. 38. ISSUE 7. P. 904 -910 32 29% 179
3 WANG, Y , LI, LZ , GUO, XQ , JIN, X , SUN, WJ , ZHANG, XL , XU, RC , (2012) INTERLEUKIN-6 SIGNALING REGULATES ANCHORAGE-INDEPENDENT GROWTH, PROLIFERATION, ADHESION AND INVASION IN HUMAN OVARIAN CANCER CELLS.CYTOKINE. VOL. 59. ISSUE 2. P. 228-236 23 52% 39
4 MASOUMI-MOGHADDAM, S , AMINI, A , WEI, AQ , ROBERTSON, G , MORRIS, DL , (2015) INTRATUMORAL INTERLEUKIN-6 PREDICTS ASCITES FORMATION IN PATIENTS WITH EPITHELIAL OVARIAN CANCER: A POTENTIAL TOOL FOR CLOSE MONITORING.JOURNAL OF OVARIAN RESEARCH. VOL. 8. ISSUE . P. - 19 63% 0
5 YU, SH , ZHENG, QZ , ESOPI, D , MACGREGOR-DAS, A , LUO, J , ANTONARAKIS, ES , DRAKE, CG , VESSELLA, R , MORRISSEY, C , DE MARZO, AM , ET AL (2015) A PARACRINE ROLE FOR IL6 IN PROSTATE CANCER PATIENTS: LACK OF PRODUCTION BY PRIMARY OR METASTATIC TUMOR CELLS.CANCER IMMUNOLOGY RESEARCH. VOL. 3. ISSUE 10. P. 1175 -1184 16 50% 4
6 CULIG, Z , STEINER, H , BARTSCH, G , HOBISCH, A , (2005) INTERIEUKIN-6 REGULATION OF PROSTATE CANCER CELL GROWTH.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 95. ISSUE 3. P. 497-505 24 33% 174
7 SAKAI, I , MIYAKE, H , TERAKAWA, T , FUJISAWA, M , (2011) INHIBITION OF TUMOR GROWTH AND SENSITIZATION TO CHEMOTHERAPY BY RNA INTERFERENCE TARGETING INTERLEUKIN-6 IN THE ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER PC3 MODEL.CANCER SCIENCE. VOL. 102. ISSUE 4. P. 769 -775 19 43% 11
8 LANE, D , MATTE, I , RANCOURT, C , PICHE, A , (2011) PROGNOSTIC SIGNIFICANCE OF IL-6 AND IL-8 ASCITES LEVELS IN OVARIAN CANCER PATIENTS.BMC CANCER. VOL. 11. ISSUE . P. - 17 44% 40
9 GU, L , TALATI, P , VOGIATZI, P , ROMERO-WEAVER, AL , ABDULGHANI, J , LIAO, ZY , LEIBY, B , HOANG, DT , MIRTTI, T , ALANEN, K , ET AL (2014) PHARMACOLOGIC SUPPRESSION OF JAK1/2 BY JAK1/2 INHIBITOR AZD1480 POTENTLY INHIBITS IL-6-INDUCED EXPERIMENTAL PROSTATE CANCER METASTASES FORMATION.MOLECULAR CANCER THERAPEUTICS. VOL. 13. ISSUE 5. P. 1246-1258 19 39% 8
10 BEN JEMAA, A , BOURAOUI, Y , BEN RAIS, N , NOUIRA, Y , OUESLATI, R , (2016) CYTOKINE PROFILING IDENTIFIES AN INTERACTION OF IL-6 AND IL-1 ALPHA TO DRIVE PSMA-PSA PROSTATE CLONES.IMMUNOBIOLOGY. VOL. 221. ISSUE 12. P. 1424 -1431 17 43% 0

Classes with closest relation at Level 1



Rank Class id link
1 2728 INTERLEUKIN 6 RECEPTOR//IL 6 RECEPTOR//GP130
2 17299 174G C//INTERLEUKIN 6//INTERLEUKIN 6 POLYMORPHISM
3 14765 CXCR2//INTERLEUKIN 8//CXCL5
4 30507 MESOTHELIAL CELLS//RAT MAMMARY CARCINOMA//ADHESION POLYPEPTIDES
5 5366 STAT3//GRIM 19//STAT3 INHIBITOR
6 30473 RS3783553//MICROENCAPSULATED CELLS//ABORAT INNOVAT HEMATOLMINIST HLTHAFFILI
7 1876 ANDROGEN RECEPTOR//GEORGE WHIPPLE CANC//CASTRATION RESISTANT PROSTATE CANCER
8 3667 GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO
9 24952 PHARMACEUT PROTE//TNFR2//TNF DEFICIENCY
10 31089 OSTEOBLASTIC METASTASIS//HUMAN BONE MARROW ENDOTHELIAL CELLS//CATTEDRA PATOL GEN

Go to start page